The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 28, 2020
Filed:
Nov. 08, 2018
Applicant:
Boehringer Ingelheim Animal Health Usa Inc., Duluth, GA (US);
Inventors:
Arun V. Iyer, Ames, IA (US);
Joseph Ralph Hermann, Waukee, IA (US);
Michael B. Roof, Ames, IA (US);
Eric Martin Vaughn, Ames, IA (US);
Merrill Lynn Schaeffer, St. Joseph, MO (US);
Assignee:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC., Duluth, GA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/569 (2006.01); G01N 33/68 (2006.01); G01N 33/50 (2006.01); A61K 39/12 (2006.01); C12Q 1/70 (2006.01); C12P 21/00 (2006.01); A61K 39/145 (2006.01); C12N 7/00 (2006.01); C07K 14/005 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/56983 (2013.01); A61K 39/12 (2013.01); A61K 39/145 (2013.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12P 21/00 (2013.01); C12Q 1/701 (2013.01); G01N 33/5091 (2013.01); G01N 33/6854 (2013.01); A61K 2039/5252 (2013.01); C07K 2319/21 (2013.01); C07K 2319/50 (2013.01); C12N 2710/14021 (2013.01); C12N 2710/14022 (2013.01); C12N 2710/14043 (2013.01); C12N 2710/14051 (2013.01); C12N 2710/14143 (2013.01); C12N 2750/10034 (2013.01); C12N 2750/10051 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16151 (2013.01); C12N 2760/20022 (2013.01); C12N 2760/20034 (2013.01); C12N 2760/20051 (2013.01); G01N 2333/01 (2013.01);
Abstract
The present invention belongs to the field of compliance markers and marker vaccines which allow for the differentiation between infected and vaccinated individuals. In particular, it relates to a method of determining whether an individual has received an immunogenic composition comprising a recombinant protein produced by a baculovirus expression system in cultured insect cells.